These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9547626)

  • 1. Efficacy of Cicaprost on metastasis in advanced tumor disease.
    Schirner M; Lichtner RB; Graf H; Schneider MR
    Adv Exp Med Biol; 1997; 400B():751-6. PubMed ID: 9547626
    [No Abstract]   [Full Text] [Related]  

  • 2. The stable prostacyclin analogue Cicaprost inhibits metastasis to lungs and lymph nodes in the 13762NF MTLn3 rat mammary carcinoma.
    Schirner M; Lichtner RB; Schneider MR
    Clin Exp Metastasis; 1994 Jan; 12(1):24-30. PubMed ID: 8287616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor metastasis inhibition with the prostacyclin analogue cicaprost depends on discontinuous plasma peak levels.
    Schirner M; Kraus C; Lichtner RB; Schneider MR; Hildebrand M
    Prostaglandins Leukot Essent Fatty Acids; 1998 Apr; 58(4):311-7. PubMed ID: 9654405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of metastasis by cicaprost in rats with established SMT2A mammary carcinoma growth.
    Schirner M; Schneider MR
    Cancer Detect Prev; 1997; 21(1):44-50. PubMed ID: 9043762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prostacyclin analogue cicaprost inhibits metastasis of tumours of R 3327 MAT Lu prostate carcinoma and SMT 2A mammary carcinoma.
    Schirner M; Schneider MR
    J Cancer Res Clin Oncol; 1992; 118(7):497-501. PubMed ID: 1624541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rodent model of systemic mammary tumor disease by surgical removal of the spontaneously metastasizing SMT2A mammary carcinoma: inhibitory effect of the stable prostacyclin analogue cicaprost on occult metastasis.
    Schirner M; Schneider MR
    Int J Cancer; 1995 Jul; 62(2):205-9. PubMed ID: 7622297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimetastatic action of the prostacyclin analogue cicaprost in experimental mammary tumors.
    Schneider MR; Schirner M; Lichtner RB; Graf H
    Breast Cancer Res Treat; 1996; 38(1):133-41. PubMed ID: 8825130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimetastatic effects of maleic anhydride-divinyl ether in rats with mammary adenocarcinoma.
    Khato J; Chirigos MA; Sieber SM
    J Immunopharmacol; 1983; 5(1-2):65-75. PubMed ID: 6655251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimetastatic effect of amiloride in an animal tumour model.
    Kellen JA; Mirakian A; Kolin A
    Anticancer Res; 1988; 8(6):1373-6. PubMed ID: 3218971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between lymphogenous and hematogenous metastasis in rats bearing the MT-100-TC mammary carcinoma.
    Ward PM; Weiss L
    Clin Exp Metastasis; 1989; 7(3):253-64. PubMed ID: 2924446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced lymph node uptake of melphalan following liposomal entrapment and effects on lymph node metastasis in rats.
    Khato J; Priester ER; Sieber SM
    Cancer Treat Rep; 1982 Mar; 66(3):517-27. PubMed ID: 7060039
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity.
    Parish CR; Freeman C; Brown KJ; Francis DJ; Cowden WB
    Cancer Res; 1999 Jul; 59(14):3433-41. PubMed ID: 10416607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneously metastasizing variants derived from MNU-induced rat mammary tumour.
    Williams JC; Gusterson BA; Coombes RC
    Br J Cancer; 1982 Apr; 45(4):588-97. PubMed ID: 7073949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cicaprost inhibits metastases of animal tumors.
    Schirner M; Schneider MR
    Prostaglandins; 1991 Nov; 42(5):451-61. PubMed ID: 1763201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of metastasis from mouse mammary carcinomas with liposomes carrying doxorubicin.
    Vaage J; Donovan D; Loftus T; Working P
    Br J Cancer; 1995 Nov; 72(5):1074-5. PubMed ID: 7577449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphatic metastasis of mammary adenocarcinoma. An experimental study in the rat with a brief review of the literature.
    Carr I; Carr J; Dreher B
    Invasion Metastasis; 1981; 1(1):34-53. PubMed ID: 6765247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of dietary fat on mammary tumor metastasis in the rat.
    Boylan ES; Cohen LA
    Nutr Cancer; 1986; 8(3):193-200. PubMed ID: 3737422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maturational agents alone or in combination with cytotoxic agents in therapy of tumor metastases.
    Milas L; Tofilon P; Iwakawa M
    Adv Exp Med Biol; 1988; 233():377-83. PubMed ID: 3223392
    [No Abstract]   [Full Text] [Related]  

  • 19. Prostacyclin and its analogues: antimetastatic effects and mechanisms of action.
    Schneider MR; Tang DG; Schirner M; Honn KV
    Cancer Metastasis Rev; 1994 Dec; 13(3-4):349-64. PubMed ID: 7712596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis and necrosis occurring during different stages of primary and metastatic tumor growth of a rat mammary adenocarcinoma.
    Matsuda H; Strebel FR; Kaneko T; Stephens LC; Danhauser LL; Jenkins GN; Toyota N; Bull JM
    Anticancer Res; 1996; 16(3A):1117-21. PubMed ID: 8702222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.